Evaluating the Prevalence of Noncoding Repeat Expansions in Amyotrophic Lateral Sclerosis
CSEF · 2013 Mammalian Biology First Award
Overview
Objectives/Goals Though no treatments for amyotrophic lateral sclerosis (ALS) currently exist, evidence suggests that the disease is strongly rooted in genetic origins. Recently, expansions of CAG (glutamine coding) repeats in several genes, including NIPA1, ataxin 2, and c9orf72, have been linked to ALS incidence, raising the possibility of a broad role for repeat expansions in ALS susceptibility. Repeat expansions in c9orf72, the most common abnormality linked to ALS as of yet, are in a noncoding region of the gene. The likely mechanism of action of these noncoding repeat expansions occurs via accumulation of toxic RNA foci, resulting in sequestration of various RNA binding proteins and general disruption of the transcriptome. I chose to investigate six candidate genes previously linked to neuromuscular disorders - NOP56, JPH3, DMPK, ATXN8, PPP2R2B, and ATXN10 - for a possible link between noncoding repeat expansions in the genes and ALS susceptibility. Methods/Materials Polymerase chain reaction, gel electrophoresis, and capillary electrophoresis were used to amplify and determine the repeat lengths of the genes of interest in 730 ALS patients and 700 control patients. In addition, this study presents an automated technique, developed in Java, of inferring allelic repeat number from fragment analysis data. This method has been successfully applied to analyze more than 4,000 individual data points for genotyping and can also be utilized for other applications of electropherograms, which are used widely in molecular biology. Results Receiver operating characteristic analysis and Fisher#s exact test revealed a significant association between ataxin 8 repeat length and ALS. Ongoing and future work includes investigating other genes for associations with ALS, refining and expanding the automated electropherogram analysis, as well as utilizing TALENs to induce these repeat expansion mutations in cell culture models in order to test the RNA foci hypothesis. Conclusions/Discussion This study has both identified a novel gene candidate associated with amyotrophic lateral sclerosis incidence and introduced a new technique of automating fragment analysis based genotyping. These findings can prove instructive in characterizing the genetic interactions which lead to ALS, paving the way for potential diagnostic methods such as genetic screening to identify ALS as early as possible.
Summary statement
This study has both identified a novel gene candidate associated with amyotrophic lateral sclerosis incidence and introduced a new technique of automating fragment analysis based genotyping.
Help received
Research performed during internship at the Gitler Lab at Stanford University
Awards (1)
Competition history
- CSEF 2013
Resources
Related projects
ISEF · 2021
A Differential Gene Expression and Alternative Splicing Analysis of ALS-Causing Mutations
CSEF · 2019
RT-qPCR Development of a New Therapeutic Avenue for Curing Amyotrophic Lateral Sclerosis (ALS)
ISEF · 2021
In Amyotrophic Lateral Sclerosis (ALS) Patient Tissue, UG Rich RNA Is Not Preferentially Soluble as Predicted
CSEF · 2006
Immunohistochemical Identification of Early Disease Markers in Amyotrophic Lateral Sclerosis
ISEF · 2024
The Relationship Between Elongator Protein 3 (ELP3) and Neurodegenerative Disease: Investigating the Neuromuscular Junction in an Elongator Mouse Model of ALS
AJAS · 2018
Understanding RNA Processing Changes Due to FUS in Amyotrophic Lateral Sclerosis (ALS) Patient Cells
ISEF · 2024
ALS-SynAegis: A Molecular Dynamics Study on TDP-43 Aggregation to Prevent Amyotrophic Lateral Sclerosis Onset
AJAS · 2025
ALS-SynAegis: A Molecular Dynamics Study on TDP-43 Aggregation to Prevent ALS Onset
Closest projects by meaning, across every fair and year in the corpus.
Browse more like this
Source: California Science & Engineering Fair public projects